Skip to content

Clinical trials

Hepatitis C, Chronic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20112
20125
20131
20141
20151
20162
20174
20184
20197
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status9
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunshine Lake Pharma Co., Ltd.7
AbbVie3
Beijing Ditan Hospital3
Kawin Technology Share-holding Co., Ltd.3
Third Affiliated Hospital, Sun Yat-Sen University3
Beijing Kawin Technology Share-Holding Co., Ltd.2
Xiamen Amoytop Biotech Co., Ltd.2
Ascletis Pharmaceuticals Co., Ltd.1
Beijing 302 Hospital1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic35
Hepatitis C9
Acquired Immunodeficiency Syndrome2
Coinfection2
Hepatitis B, Chronic2
Liver Diseases2
Carcinoma, Hepatocellular1
Drug-Related Side Effects and Adverse Reactions1
Fibrosis1
Hepadnaviridae Infections1

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.